These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27605421)

  • 61. Combination of circulating microRNAs as indicators of specific targets of retinal toxicity in rats.
    Kakiuchi D; Taketa Y; Ohta E; Fujikawa Y; Nakano-Ito K; Asakura S; Hosokawa S
    Toxicology; 2019 Jan; 411():163-171. PubMed ID: 30336191
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
    Sun Y; Wang X; Wang Z; Zhang Y; Che N; Luo X; Tan Z; Sun X; Li X; Yang K; Wang G; Luan L; Liu Y; Zheng X; Wei M; Cheng H; Yin J
    Epilepsy Res; 2016 Nov; 127():276-283. PubMed ID: 27689807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Vegter EL; Schmitter D; Hagemeijer Y; Ovchinnikova ES; van der Harst P; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield D; Cotter G; Cleland JG; Givertz MM; Ponikowski P; van Veldhuisen DJ; van der Meer P; Berezikov E; Voors AA; Khan MA
    Int J Cardiol; 2016 Dec; 224():231-239. PubMed ID: 27661412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.
    Yao XL; Lu XL; Yan CY; Wan QL; Cheng GC; Li YM
    Int J Clin Exp Pathol; 2015; 8(12):16014-9. PubMed ID: 26884877
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A MicroRNA Signature for Evaluation of Risk and Severity of Autoimmune Thyroid Diseases.
    Martínez-Hernández R; Sampedro-Núñez M; Serrano-Somavilla A; Ramos-Leví AM; de la Fuente H; Triviño JC; Sanz-García A; Sánchez-Madrid F; Marazuela M
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1139-1150. PubMed ID: 29325052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of urinary microRNA biomarkers for
    Jeon BS; Lee SH; Hwang SR; Yi H; Bang JH; Tham NTT; Lee HK; Woo GH; Kang HG; Ku HO
    J Vet Sci; 2020 Nov; 21(6):e81. PubMed ID: 33263228
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage.
    Wolenski FS; Shah P; Sano T; Shinozawa T; Bernard H; Gallacher MJ; Wyllie SD; Varrone G; Cicia LA; Carsillo ME; Fisher CD; Ottinger SE; Koenig E; Kirby PJ
    J Appl Toxicol; 2017 Mar; 37(3):278-286. PubMed ID: 27397436
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS.
    Takeuchi M; Oda S; Tsuneyama K; Yokoi T
    Arch Toxicol; 2018 Sep; 92(9):2947-2962. PubMed ID: 30019166
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.
    Roest HP; IJzermans JNM; van der Laan LJW
    BMC Biotechnol; 2021 Aug; 21(1):48. PubMed ID: 34362351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary microRNAs miR-15b and miR-30a as novel noninvasive biomarkers for gentamicin-induced acute kidney injury.
    Sun B; Qu Z; Cheng GL; Yang YW; Miao YF; Chen XG; Zhou XB; Li B
    Toxicol Lett; 2021 Mar; 338():105-113. PubMed ID: 33290828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.
    Laterza OF; Lim L; Garrett-Engele PW; Vlasakova K; Muniappa N; Tanaka WK; Johnson JM; Sina JF; Fare TL; Sistare FD; Glaab WE
    Clin Chem; 2009 Nov; 55(11):1977-83. PubMed ID: 19745058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis.
    Chen J; Li K; Pang Q; Yang C; Zhang H; Wu F; Cao H; Liu H; Wan Y; Xia W; Wang J; Dai Z; Li Y
    Sci Rep; 2016 Nov; 6():36347. PubMed ID: 27821865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Screening plasma miRNAs as biomarkers for renal ischemia-reperfusion injury in rats.
    Wang JF; Zha YF; Li HW; Wang F; Bian Q; Lai XL; Yu G
    Med Sci Monit; 2014 Feb; 20():283-9. PubMed ID: 24553149
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the Relative Performance of Pancreas-Specific MicroRNAs in Rat Plasma as Biomarkers of Pancreas Injury.
    Erdos Z; Barnum JE; Wang E; DeMaula C; Dey PM; Forest T; Bailey WJ; Glaab WE
    Toxicol Sci; 2020 Jan; 173(1):5-18. PubMed ID: 31504967
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
    Schulte C; Barwari T; Joshi A; Theofilatos K; Zampetaki A; Barallobre-Barreiro J; Singh B; Sörensen NA; Neumann JT; Zeller T; Westermann D; Blankenberg S; Marber M; Liebetrau C; Mayr M
    Circ Res; 2019 Jul; 125(3):328-340. PubMed ID: 31159652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis.
    Myklebust MP; Rosenlund B; Gjengstø P; Bercea BS; Karlsdottir Á; Brydøy M; Dahl O
    Front Genet; 2019; 10():463. PubMed ID: 31191602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR.
    Wolfinger RD; Beedanagari S; Boitier E; Chen T; Couttet P; Ellinger-Ziegelbauer H; Guillemain G; Mariet C; Mouritzen P; O'Lone R; Pine PS; Sharapova T; Yan J; Yuen PS; Thompson KL
    BMC Biotechnol; 2018 Feb; 18(1):6. PubMed ID: 29391006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.